Prevent Overview

  • Founded
  • 2002
  • Status
  • Acquired/​Merged
  • Employees
  • 3
  • Latest Deal Type
  • M&A

Prevent General Information


Provider of on-site health screenings designed to be delivered within the workplace or even individual homes of employees. The company's health screenings and occupational health risk surveillance assessment programs are provided to company employees, enabling a cost effective and cheaper method of health screening to be conducted as opposed to the ones that need to be conducted in a clinic or private hospital.

Contact Information

Ownership Status
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Other Healthcare Services
Parent Company
Health Shield Friendly Society
Primary Office
  • P.O.Box 514
  • Weybridge KT13 8QL
  • England, United Kingdom
+44 01932 000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Prevent Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 12-Jan-2017 Completed Generating Revenue
1. Early Stage VC Completed Generating Revenue
To view Prevent’s complete valuation and funding history, request access »

Prevent Executive Team (1)

Name Title Board Seat Contact Info
Carl Laidler Managing Director
To view Prevent’s complete executive team members history, request access »

Prevent Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Prevent Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Lacomp Asset Manager Minority 000 0000 000000 0
To view Prevent’s complete investors history, request access »